Newsroom
Stay informed on our latest company updates, scientific advancements, clinical milestones, and corporate announcements as we continue advancing NLRP3-based medicines.
NodThera to Participate in April Investor Conferences
Thera says inflammation drug has positive effect in Parkinson’s
Biopharma Dive
NodThera to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Geoff McDonough’s big plans for NodThera’s NLRP3
Endpoints